ESMO Clinical Practice Guidelines: Endocrine and Neuroendocrine Cancers
Latest enhanced and revised set of guidelines
ESMO has four Clinical Practice Guidelines on Neuroendocrine tumours: adrenocortical carcinomas and malignant phaeochromocytomas, gastroenteropancreatic neuroendocrine neoplasms, lung and thymic carcinoids and thyroid cancer. They include information on incidence, diagnosis, staging and risk assessment, treatment, response evaluation and follow-up.